Lymphangioleiomyomatosis
📧 Sign up to get email alerts when something new happens for Lymphangioleiomyomatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease [Phase 1]
Phase 1 trial evaluating bevacizumab and temsirolimus alone or with valproic acid or cetuximab in patients with advanced or metastatic malig…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis [Phase 1, Phase 2]
This clinical trial is evaluating nebulized or inhaled albuterol as a treatment for lymphangioleiomyomatosis in Phase 1 and Phase 2. The stu…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of the Disease Process of Lymphangioleiomyomatosis
NHLBI-sponsored clinical trial update focusing on the disease process of lymphangioleiomyomatosis, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
A pregnancy registry for Tuberous Sclerosis Complex and Lymphangioleiomyomatosis is currently recruiting, sponsored by David M. Ritter.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM) [Phase 1]
A Phase 1 clinical trial update evaluating the long-term safety and tolerability of imatinib in patients with lymphangioleiomyomatosis (LAM)…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
A University of Milan trial is recruiting to evaluate extracellular vesicles as biomarkers of pulmonary involvement in lymphangioleiomyomato…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: TSC Biosample Repository and Natural History Database
Recruiting study to create a biosample repository and natural history database for tuberous sclerosis complex and lymphangioleiomyomatosis.
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: National Lymphangioleiomyomatosis Registry, France
This entry reports on the National Lymphangioleiomyomatosis Registry in France, sponsored by Vincent Cottin. The study is currently recruiti…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Safety and Durability of Sirolimus for Treatment of LAM
This clinical trial update reports ongoing safety and durability evaluation of sirolimus for lymphangioleiomyomatosis with recruitment conti…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial [Phase 3]
A multicenter Phase 3 interventional trial for early-stage lymphangioleiomyomatosis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
This clinical trial update notes that the breath analysis and arterial stiffness study in patients with various respiratory diseases is curr…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: The Genotype and Phenotype of Lymphangioleiomyomatosis
This clinical trial update describes an ongoing genotype and phenotype study of lymphangioleiomyomatosis (including sporadic and TSC-associa…
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Lymphangioleiomyomatosis (LAM) Registry
An update on the Lymphangioleiomyomatosis (LAM) patient registry sponsored by NHLBI; the study status is completed.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)
Official clinical trials record indicating a completed study related to lymphangioleiomyomatosis (LAM).